Combretum lanceolatum flowers ethanol extract inhibits hepatic gluconeogenesis: an in vivo mechanism study

Abstract

Context Ethnopharmacological studies have demonstrated that plants of the Combretum genus presented antidiabetic activity, including Combretum lanceolatum Pohl ex Eichler (Combretaceae). Objective This study investigated the hepatic mechanisms of action of C. lanceolatum flowers ethanol extract (ClEtOH) related to its antihyperglycaemic effect in streptozotocin-diabetic rats. Materials and methods Male Wistar rats were divided into normal (N) and diabetic control (DC) rats treated with vehicle (water); diabetic rats treated with 500 mg/kg metformin (DMet) or 500 mg/ kg ClEtOH (DT500). After 21 d of treatment, hepatic glucose and urea production were investigated through in situ perfused liver with L-glutamine. Changes in the phosphoenolpyruvate carboxykinase (PEPCK) levels and in the activation of adenosine monophosphate-activated protein kinase (AMPK) and insulin-signalling intermediates were also investigated. Results Similar to DMet, DT500 rats showed a reduction in the rates of hepatic production of glucose (46%) and urea (22%) in comparison with DC. This reduction was accompanied by a reduction in the PEPCK levels in liver of DT500 (28%) and DMet (43%) when compared with DC. AMPK phosphorylation levels were higher in the liver of DT500 (17%) and DMet (16%) rats. The basal AKT phosphorylation levels were increased in liver of DT500 rats, without differences in the insulin-stimulated AKT phosphorylation and in the insulin receptor levels between DC and DT500 rats. Discussion and conclusion The antidiabetic activity of ClEtOH can be attributed, at least in part, to inhibition of hepatic gluconeogenesis, probably due to the activation of both AMPK and AKT effectors and reduction in the PEPCK levels.ARTICLE HISTORY

Potential Role of Mitochondria as Modulators of Blood Platelet Activation and Reactivity in Diabetes and Effect of Metformin on Blood Platelet Bioenergetics and Platelet Activation

“…Study limitations: A wide range of metformin concentrations (50–500 mg/kg/day) have been used in in vivo studies assessing the effects of metformin in laboratory rat models of diabetes [ 35 , 36 , 37 , 38 , 39 ]. However, only two doses were used to evaluate the impact of this drug on pro-aggregatory function of platelets: 400 mg/kg/day for 7 days was used to evaluate the impact of metformin on platelet aggregation [ 20 ] and 300 mg/kg/day for 15 days to evaluate its impact on vascular function in diabetic rats [ 40 ].…”

Anti-Diabetic Effects of Cucurbitacins from Ibervillea lindheimeri on Induced Mouse Diabetes

“…e anti-hyperglycemic activity has also been associated with inhibiting hepatic glucose liberation [16]. Additionally, treatment with 1, 2, 3, or 4 did not cause undesired effects, such as acute diarrhea, vomiting, gastrointestinal bleeding, hypotension, or irritation of mucous membranes, as previously described for so-called cucurbitacin poisoning [38,39], even when 2 and 4 were tested at doses as high as 500 mg/kg [7,37].…”

“…is effect has been reported for metformin, cucurbitacin derivatives, and 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR), which is an activator of AMPK. is kinase is involved in glucose clearance by promoting Glut4 translocation via a mechanism of action independent of insulin [9,36,37].…”

Buscando Soluções Sustentáveis para Áreas Úmidas savânicas florestadas brasileiras via uso múlti

“…Atualmente há diversos valores econômicos das AUs savânicas reconhecidos, como, por exemplo, pecuária extensiva (Da Silva & Girard 2004, Soares et al 2009, Hoogesteijn & Hoogesteijn 2010), ecoturismo (Zimmermann et al 2005, Hoogesteijn & Hoogesteijn 2010), fitoterápicos (Schmeda-Hirschmann et al 2014, Dall'Oglio et al 2015, Santos et al 2016, Siqueira et al 2016) e pesca (Resende & Santos 2002, Mateus et al 2004, Almeida & Resende 2012, Polaz et al 2014, Barletta et al 2016.…”